최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기동의생리병리학회지 = Journal of physiology & pathology in Korean Medicine, v.21 no.6, 2007년, pp.1437 - 1449
오명택 (동의대학교 한의과대학 병리학교실) , 엄현섭 (동의대학교 한의과대학 병리학교실) , 지규용 (동의대학교 한의과대학 병리학교실)
In this study, the effect of extract of Corydalis yanhusuo (ECT) used in Oriental medicine therapy was investigated on the cell growth and apoptosis of HepG2 human hepatoma cells. It was found that ECT could inhibit the cell growth effectively in a dose-dependent manner, which was associated with mo...
Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S. and Peter, M.E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254: 439-459, 1998
Chiarugi, V., Magnelli, L., Cinelli, M. and Basi, G. Apoptosis and the cell cycle. Cell Mol. Biol Res. 40: 603-612, 1994
Lee, K.H., Huh, J.W., Choi, M.M., Yoon, S.Y., Yang, S.J., Hong, H.N., Cho, S.W. Regulation of glutamate level in rat brain through activation of glutamate dehydrogenase by Corydalis ternata. Exp Mol Med. 37(4):371-377, 2005
Chung, Y.T., Park, S.T., Mun, J.Y., Kim, J.M., Choi, M.K., Han, D.S. and Kim, B. Cytotoxic effects of actinomycin D, adriamycin and puromycin in the development stage of early mouse embryos. J. Wonkwang Medical Sci. 3: 13-34, 1987
李時珍. 本草綱目. 고문사, 서울, p 467, 1973
전국한의대본초학교수 공편. 本草學. 영림사, 서울, pp 413-414, 1998
Yuan, C.S., Mehendale, S.R., Wang, C.Z., Aung, H.H., Jiang, T., Guan, X., Shoyama, Y. Effects of Corydalis yanhusuo and Angelicae dahuricae on cold pressor-induced pain in humans: a controlled trial. J Clin Pharmacol. 4(11):1323-1327, 2004
國家藥典委員會編. 中華人民共和國藥典. 化學工業出版社, 北京, p 108, 2000
식품의약품안전청 홈페이지, http://herbmed.kfda.go.kr /herb /search_details.jsp?codeKP-056
江蘇新醫學院編, 中藥大辭典上. 上海科技出版社, 上海, p 921, 1978
홍성범. 임상항암중초약. 성보사, 서울, pp 236-238, 265, 1998
Cossarizza, A., Cooper, E.L., Quaglino, D., Salvioli, S., Kalachnikova, G. and Franceschi, C. Mitochondrial mass and membrane potential in coelomocytes from the earthworm Eisenia foetida: studies with fluorescent probes in single intact cells. Biochem. Biophys. Res. Commun. 14: 503-510, 1995
Guo, W.X., Pye, Q.N., Williamson, K.S., Stewart, C.A., Hensley, K.L., Kotake, Y., Floyd, R.A. and Broyles, R.H. Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes. Free Radic. Biol. Med. 39: 641-665, 2005
Elledge, S.J. and Harper, J.W. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6: 847-852, 1994
Li, Y., Jenkins, C.W., Nichols, M.A. and Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene, 9: 2261-2268, 1994
Datto, M.B., Yu, Y. and Wang ,X.F. Functional analysis of thetransforming growth factor $\beta$ responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270: 28623-28628, 1995
Morgan, D.O. Principles of CDK regulation. Nature, 374: 131-134, 1995
Rosse, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B. and Borner, C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature, 391: 496-499, 1998
Sheikh, M.S. and Huang, Y. Death receptors as targets of cancer therapeutics. Curr. Cancer Drug Targets, 4: 97-104, 2004
Klas, C., Debatin, K.M., Jonker, R.R. and Krammer, P.H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol, 5: 625-630, 1993
Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.P., Nicholl, J.K., Sutherland, G.R., Smith T.D., Rauch, C., Smith, C.A., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995
Ashkenazi, A., Pai, R.C., Fong, S., Leung, S., Lawrence, D.A., Marsters, S.A., Blackie, C., Chang, L., McMurtrey, A.E., Hebert, A., DeForge, L., Koumenis, I.L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z. and Schwall, R.H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104: 155-162, 1999
Ashkenazi, A. and Dixit, V.M. Death receptors: signaling and modulation. Science, 281: 1305-1308, 1998
Tibbetts, M.D., Zheng, L. and Lenardo, M.J. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4: 404-409, 2003
Fulda, S. and Debatin, K.M. Exploiting death receptor signaling pathways for tumor therapy. Biochem. Biophys. Acta. 1705: 27-41, 2004.
Allen, R.T., Cluck, M.W. and Agrawal, D.K. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol. Life Sci. 54: 427-445, 1998
Vegran, F., Boidot, R., Oudin, C., Riedinger, J.M. and Lizard-Nacol, S. Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance. Bull Cancer, 92: 219-226, 2005.
Holcik, M., Gibson, H. and Korneluk, R.G. XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 6: 253-261, 2001
Cheng, J.Q., Jiang, X., Fraser, M., Li, M., Dan, H.C., Sun, M. and Tsang, B.K. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist. 5: 131-146, 2002
Tewari, M., Quan, L.T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S. and Dixit, V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81: 801-809, 1995
Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E. and Poirier, G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53: 3976-3985, 1993
Johnson, J.P. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 18: 345-357, 1999
Fukuda, K. Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. Int, J, Biochem, Cell Biol. 31: 519-529, 1999
Chang, J.S., Noh, D.Y., Park, I.A., Kim, M.J., Song, H., Ryu, S.H. and Suh, P.G. Overexpression of phospholipase C-gamma1 in rat 3Y1 fibroblast cells leads to malignant transformation. Cancer Res. 57: 5465-5468, 1997
Myklebust, J.H., Blomhoff, H.K., Rusten, L.S., Stokke, T. and Smeland, E.B. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. Exp, Hematol. 30: 990-1000, 2002
Giercksky, K.E. COX-2 inhibition and prevention of cancer. Best Pract. Res. Clin. Gastroenterol. 15: 821-833, 2001
Vainio, H. Is COX-2 inhibition a panacea for cancer prevention? Int. J. Cancer. 94: 613-614, 2001
Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E.S., Sasaki, Y., Kawano, S. and Hori, M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest. 79: 1469-1477, 1999
Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K. and Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kB activation. Mutat. Res. 480: 243-268, 2001
Poole, J.C., Andrews, L.G. and Tollefsbol, T.O. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene. 269: 1-12, 2001
Vaziri, H., West, M.D., Allsopp, R.C., Davison, T.S., Wu, Y.S., Arrowsmith, C.H., Poirier, G.G. and Benchimol, S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 16: 6018-6033, 1997
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.